Show simple item record

dc.contributor.authorAllen, Claire
dc.date.accessioned2020-03-24T18:35:22Z
dc.date.available2020-03-24T18:35:22Z
dc.date.issued2020-03-18
dc.identifier.urihttps://www.evidenceaid.org/extracorporeal-membrane-oxygenation-ecmo-for-patients-with-acute-respiratory-failure-uncertain-if-it-is-better-or-worse-than-conventional-lung-support/en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/773
dc.description.abstractWhat is this? Some patients with COVID-19 will become critically ill and need help with their breathing. Extracorporeal membrane oxygenation (ECMO) is a form of life support that targets the heart and lungs and which might be used for them. In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials testing the use of ECMO for acute respiratory failure. They did not restrict by language or location of publication and did their searches in August 2014. They identified 4 randomized trials which compared ECMO versus conventional lung support (389 participants).en_US
dc.languageEnglishen_US
dc.subjectExtracorporeal Membrane Oxygenationen_US
dc.subjectLung Diseasesen_US
dc.subjectRespiratory Distressen_US
dc.subjectCOVID-19en_US
dc.subjectInfectious Diseasesen_US
dc.titleExtracorporeal membrane oxygenation (ECMO) for patients with acute respiratory failure: Uncertain if it is better or worse than conventional lung supporten_US
eihealth.countryOthersen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySlow Spread / Reducir la Dispersiónen_US
dc.relation.ispartofjournalEvidence Aiden_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record